Epstein Secrets

e AP (10/22, Marchione) reports that the "antiviral medicine given to hospitalized patients through an IV," being marketed by manufacturer Gilead as Veklury, "cut the time to recovery by five days - from 15 days to 10 on average - in a large study led by the U.S. National Institutes of Health." The drug

States "joined Brazil, Egypt, Hungary, Indonesia and Uganda...to co-sponsor a nonbinding international dedaration opposing abortion, in a rebuke of the U.N. Human Rights Council, which has enshrined abortion access as a universal right." WPost Analysis: Bolivia Returns To Morales After Year Of Turmoil. The Washington Post

63> (10/22, Marchione) reports that the "antiviral medicine given to hospitalized patients through an IV," being marketed by manufacturer Gilead as Veklury, "cut the time to recovery by five days - from 15 days to 10 on average — in a large study led by the U.S. National Institutes of Health." The drug

States "joined Brazil, Egypt, Hungary, Indonesia and Uganda...to co-sponsor a nonbinding international declaration opposing abortion, in a rebuke of the U.N. Human Rights Council, which has enshrined abortion access as a universal right." WPost Analysis: Bolivia Returns To Morales After Year Of Turmoil. The Washington Post

e AP (10/22, Marchione) reports that the "antiviral medicine given to hospitalized patients through an IV," being marketed by manufacturer Gilead as Veklury, "cut the time to recovery by five days - from 15 days to 10 on average - in a large study led by the U.S. National Institutes of Health." The drug

tates "joined Brazil, Egypt, Hungary, Indonesia and Uganda...to co-sponsor a nonbinding international declaration opposing abortion, in a rebuke of the U.N. Human Rights Council, which has enshrined abortion access as a universal right." WPost Analysis: Bolivia Returns To Morales After Year Of Turmoil. The Washington Post